Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novan Inc (NOVN)

Novan Inc (NOVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 266,900
  • Shares Outstanding, K 150,791
  • Annual Sales, $ 4,920 K
  • Annual Income, $ -29,290 K
  • 60-Month Beta -0.05
  • Price/Sales 49.65
  • Price/Cash Flow N/A
  • Price/Book 67.50
Trade NOVN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +587,747.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +34.30%
on 02/04/21
2.5900 -37.26%
on 02/16/21
+0.4150 (+34.30%)
since 02/03/21
3-Month
0.5500 +195.45%
on 12/10/20
2.5900 -37.26%
on 02/16/21
+1.0663 (+190.85%)
since 12/03/20
52-Week
0.2800 +480.36%
on 03/17/20
2.5900 -37.26%
on 02/16/21
+1.2550 (+339.19%)
since 03/03/20

Most Recent Stories

More News
Novan Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors

Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced the election of Steven D. Skolsky to its Board of Directors.

NOVN : 1.6150 (-8.76%)
Thinking about buying stock in Aslan Pharmaceuticals, electroCore, Novan, OpGen, or Salarius Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ASLN, ECOR, NOVN, OPGN, and SLRX.

ASLN : 3.78 (-12.30%)
ECOR : 2.40 (-4.76%)
NOVN : 1.6150 (-8.76%)
SLRX : 1.7100 (-8.56%)
OPGN : 1.98 (-3.88%)
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD

Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration...

HTSUF : 42.0500 (unch)
NOVN : 1.6150 (-8.76%)
Thinking about buying stock in Ampio Pharmaceuticals, Motus GI, Phio Pharmaceuticals, Novan, or Oncolytics Biotech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMPE, MOTS, PHIO, NOVN, and ONCY.

AMPE : 1.5300 (-7.27%)
MOTS : 1.3300 (-7.64%)
NOVN : 1.6150 (-8.76%)
ONCY : 3.22 (+1.58%)
PHIO : 3.09 (-4.04%)
Thinking about buying stock in PAVmed, Kintara Therapeutics, Seelos Therapeutics, Novan, or Verastem?

KTRA : 1.98 (-3.41%)
NOVN : 1.6150 (-8.76%)
SEEL : 3.04 (+0.66%)
VSTM : 2.35 (-1.26%)
PAVM : 4.29 (-1.38%)
Thinking about buying stock in Artelo Biosciences, Xeris Pharmaceuticals, Inovio Pharmaceuticals, Novan, or Fisker?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARTL, XERS, INO, NOVN, and FSR.

ARTL : 1.92 (-4.00%)
INO : 9.52 (-4.99%)
NOVN : 1.6150 (-8.76%)
XERS : 5.11 (+0.20%)
FSR : 25.57 (-9.49%)
Thinking about buying stock in Novan, Baudax Bio, Tyme Technologies, Orchard Therapeutics, or electroCore?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOVN, BXRX, TYME, ORTX, and ECOR.

BXRX : 1.3250 (-1.85%)
ECOR : 2.40 (-4.76%)
NOVN : 1.6150 (-8.76%)
ORTX : 7.74 (+6.32%)
TYME : 2.00 (unch)
Thinking about buying stock in InspireMD, iBio, Nokia, Novan, or T2 Biosystems?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NSPR, IBIO, NOK, NOVN, and TTOO.

IBIO : 1.6800 (-2.33%)
NSPR : 0.8310 (-1.07%)
NOVN : 1.6150 (-8.76%)
TTOO : 2.15 (-3.15%)
NOK : 4.01 (-0.74%)
Novan Regains Compliance with Nasdaq Minimum Bid Price Requirement

Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it has received written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's...

NOVN : 1.6150 (-8.76%)
Thinking about buying stock in Acer Therapeutics, Zomedica, Novan, Atossa Therapeutics, or Tellurian?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACER, ZOM, NOVN, ATOS, and TELL.

ZOM : 2.14 (+0.94%)
NOVN : 1.6150 (-8.76%)
ACER : 3.39 (+6.27%)
ATOS : 2.61 (-3.69%)
TELL : 2.67 (-4.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through...

See More

Key Turning Points

3rd Resistance Point 2.4200
2nd Resistance Point 2.2500
1st Resistance Point 2.0100
Last Price 1.6150
1st Support Level 1.6000
2nd Support Level 1.4300
3rd Support Level 1.1900

See More

52-Week High 2.5900
Fibonacci 61.8% 1.7076
Last Price 1.6150
Fibonacci 50% 1.4350
Fibonacci 38.2% 1.1624
52-Week Low 0.2800

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar